Bayesian Revision of the Decision Rule for the Classification of Systemic Lupus Erythematosus

Conference paper
Part of the Medizinische Informatik und Statistik book series (MEDINFO, volume 62)


In November 1982, a Subcommittee of the American Rheumatism Association published (1) the revised criteria for the classification of systemic lupus erythematosus (SLE), updating the preliminary list of criteria in use since 1971 (2). As reported by Tan et al., the Subcommittee evaluated 177 patients with SLE, contributed by 18 major institutions from the United States and Canada. The control group comprised 162 age-, sex.-, and race-matched patients with a variety of non-traumatic, non-degenerate connective-tissue diseases. Ninety-five patients in the control group had confirmed rheumatoid arthritis, 16 had scleroderma, 7 had juvenile onset arthritis, 6 had dermatomyositis, and 5 each had ankylosing spondolylitis and psoriatic arthritis. The remaining 28 patients in the control group had been diagnosed to have one of l6 other diseases. Thirty potential criteria variables, including each of the original 1971 preliminary criteria, were analyzed, and 11 were selected for a final set. The 11 final criteria were: malar rash (MAL); discoid rash (DIS); photosensitivity (PHO); oral ulcers (ORA); non-erosive arthritis (ART); serositis (SER); renal disorder (REN) consisting of persistent proteinuria or cellular casts; neurologic disorder (NEU) consisting of seizures or psychosis; hematologic disorder (HEM) consisting of hemolytic anemia or leukopenia or lymphopenia or thrombocytopenia; immunologic disorder (IMM) consisting of positive LE cell preparation or abnormal titers of antibody to native DNA or Sm nuclear antigen or a false positive serologic test for syphilis; abnormal titers of antinuclear antibody (ANA).


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosustosus. Arthritis Rheum 25:1271–1277, 1982.CrossRefGoogle Scholar
  2. 2.
    Cohen AS, Reynolds WE, Franklin EC, Kulka JP, Ropes MW, Schulman LE, Wallace SL: Preliminary criteria for the classification of systemic lupus erythematosus. Bull Rheum Dis 21:643–648, 1971.Google Scholar
  3. 3.
    Fessel JW: Systemic lupus erythematosus in the community. Incidence, prevalence, outcome, and first symptoms; the high prevalence in black women. Arch Intern Med 134:1027–1035, 1974.CrossRefGoogle Scholar
  4. 4.
    Weinstein MC, Fineberg HV, Elstein AS, Frazier HS, Newhauser D, Neutra RR, McNeil BJ: Clinical decision analysis. Philadelphia, WB. Saunders, 1980, p 94.Google Scholar
  5. 5.
    Canoso JJ, Cohen AS: A review of the use, evaluations, and criticisms of the preliminary criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 22:917–921, 1979.CrossRefGoogle Scholar
  6. 6.
    Fries JF: Disease criteria for systemic lupus erythematosus. Arch Intern Med 144:252–253, 1984.CrossRefGoogle Scholar
  7. 7.
    Pollak VE: Antinuclear antibodies in families of patients with systemic lupus erythematosus. N Engl J Med 271:165–171, 1964.CrossRefGoogle Scholar
  8. 8.
    Leonardt T: Family studies in systemic lupus erythematosus. ACTA Med Scand 4l6 (S);95–98, 1964.Google Scholar
  9. 9.
    Zweinman. B, Kornblum J, Cornog J, Hildreth EA: The prognosis of lupus nephritis. Ann Intern Med 69:441–462, 1968.Google Scholar
  10. 10.
    Estes D, Christian CL: The natural history of systemic lupus erythematosus by prospective analysis. Medicine 50:85–94, 1971.CrossRefGoogle Scholar
  11. 11.
    Bartholomew BA: Antinuclear antibody tests as a clinically selected screening procedure. Amer J Clin Path 61:495–499, 1973.Google Scholar
  12. 12.
    Lee P, Urowitz MB, Bookman AAM, Kohler BE, Smythe HA, Gordon DA, Ogryzlo MA: Systemic lupus erythematosus: a review of 110 cases with reference to nephritis, the nervous system, infections, aseptic necrosis and prognosis. Quart J Med 181:1–32, 1977.Google Scholar
  13. 13.
    Fessel JW: ANA-negative systemic lupus erythematosus. Amer J Med 64:80–86, 1978.CrossRefGoogle Scholar
  14. 14.
    Gladman DD, Chalmbers A, Urowitz MB: Systemic lupus erythematosus with negative LE cells and antinuclear factor. J Rheumatol 5:142–147, 1978.Google Scholar
  15. 15.
    Maddison PJ, Provost TT, Reichlin M: Serological findings in patients with “ANA-negative” systemic lupus erythematosus. Medicine 60:87–94, 1981.CrossRefGoogle Scholar
  16. 16.
    Manu P: Receiver operating characteristic curves of the revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 26:1054–1055, 1983.CrossRefGoogle Scholar
  17. 17.
    Schur P: Systemic lupus erythematosus. In Wyngaarden JB, Smith LH Jr (Editors): Cecil Textbook of Medicine, l6th Edition, WB Saunders Company, 1852-1857, 1982.Google Scholar
  18. 18.
    Clough JD, Elrazak M, Calabrese LH, Valenzuela R, Braun WB, Williams GW: Weighted criteria for the diagnosis of systemic lupus erythematosus. Arch Intern Med 144:281–285, 1984.CrossRefGoogle Scholar
  19. 19.
    Siegel M, Holley HL, Lee SL: Epidemiologic studies on systemic lupus erythematosus: Comparative data for New York City and Jefferson County, Alabama, 1956–1965. Arthritis Rheum 13:802–811, 1970.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1985

Authors and Affiliations

  • P. Manu
    • 1
  1. 1.Department of MedicineUniversity of Connecticut School of MedicineFarmingtonUSA

Personalised recommendations